组织学亚型对肌层浸润性膀胱癌放疗后临床结局的影响
本多中心回顾性研究纳入2001至2018年864例接受根治性膀胱放疗的肌层浸润性膀胱癌患者,其中122例(14%)为尿路上皮癌组织学亚型。亚型组与纯尿路上皮癌组的完全缓解率和生存结局均无统计学差异,多因素Cox回归显示亚型状态与生存结局无关。
要点
- 864例接受膀胱放疗的肌层浸润性膀胱癌中,122例(14%)为组织学亚型。
- 纯尿路上皮癌组完全缓解率69%,组织学亚型组63%。
- 组织学亚型与完全缓解及生存结局无统计学显著差异(多因素Cox回归)。
核心结论
- 在本研究中,组织学亚型对放疗有反应,其完全缓解率和生存结局与纯尿路上皮癌相比无显著差异。
- 肌层浸润性膀胱癌中存在组织学亚型似乎并不导致放疗抵抗,患者不应被排除在膀胱保留治疗选择之外。
- 由于例数较少,无法对特定组织学亚型得出确定性结论。
研究设计与样本
- 多中心回顾性研究,纳入2001至2018年间864例接受根治性膀胱放疗的肌层浸润性膀胱癌患者(临床T2-T4aN0-2M0)。
主要发现
- 122例(14%)患者为组织学亚型;其中75例(61%)为伴鳞状和/或腺样分化的组织学亚型。
- 纯尿路上皮癌组确认完全缓解69%,组织学亚型组63%。
- 纯尿路上皮癌组207例(28%)死于转移性膀胱癌,组织学亚型组31例(25%)。
- 纯尿路上皮癌组361例(49%)死于任何原因,组织学亚型组58例(48%)。
- 两组生存结局无统计学差异,多因素Cox回归分析显示组织学亚型状态与生存结局无关。
关键数值与推荐
- 完全缓解:纯尿路上皮癌组69% vs 组织学亚型组63%。
- 死于转移性膀胱癌:纯尿路上皮癌组207例(28%) vs 组织学亚型组31例(25%)。
- 死于任何原因:纯尿路上皮癌组361例(49%) vs 组织学亚型组58例(48%)。
临床怎么用
- 作者认为,肌层浸润性膀胱癌中存在组织学亚型似乎并不导致放疗抵抗,患者不应被排除在膀胱保留治疗选择之外。
局限性
- 由于例数较少,无法对特定组织学亚型得出确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Outcomes of radiation-based therapy (RT) for muscle-invasive bladder cancer (MIBC) with histologic subtypes of urothelial cancer (HS-UC) are lacking. Our objective was to compare survival outcomes of pure urothelial carcinoma (PUC) to HS-UC after RT. MATERIALS AND METHODS: A multicenter retrospective study of 864 patients with MIBC who underwent curative-intent RT to the bladder for MIBC (clinical T2-T4aN0-2M0) between 2001 and 2018 was conducted. Regression models were used to test the association between HS-UC and complete response (CR) and survival outcomes after RT. RESULTS: In total, 122 patients (14%) had HS-UC. Seventy-five (61%) had HS-UC with squamous and/or glandular differentiation. A CR was confirmed in 69% of patients with PUC and 63% with HS-UC. There were 207 (28%) and 31 (25%) patients who died of metastatic bladder cancer in the PUC and HS-UC groups, respectively. There were 361 (49%) and 58 (48%) patients who died of any cause in the PUC and HS-UC groups, respectively. Survival outcomes were not statistically different between the groups. The HS-UC status was not associated with survival outcomes in multivariable Cox regression analyses. CONCLUSIONS: In our study, HS-UC responded to RT with no significant difference in CR and survival outcomes compared to PUC. The presence of HS-UC in MIBC does not seem to confer resistance to RT, and patients should not be withheld from bladder preservation therapy options. Due to low numbers, definitive conclusions cannot be drawn for particular histologic subtypes.
引用
- Halstuch D, Kool R, Marcq G, et al. The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer. J Urol. 2024. PMID: 39051515. doi:10.1097/JU.0000000000004160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。